It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...

From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.

MALMO, SWEDEN / ACCESSWIRE / December 17, 2024 / Ascelia Pharma (STO:ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced that two scientific abs ...

An immunofluorescence image of an aged mouse liver. Expression of β-galactosidase (white ... points to new opportunities to ...

MCCLEAN, VA, UNITED STATES, December 16, 2024 /EINPresswire / -- Perthera, the leader in AI-driven Precision Oncology Decision Support, has unveile ...

RemeGen’s Phase III trial of disitamab vedotin shows improved progression-free survival in advanced breast cancer patients ...

Hepatologist Dr SK Sarin, speaking at Agenda Aaj Tak, urged people to look for inherited diseases and not wealth to assess a ...

Researchers presented data from trials of HER2-targeted therapies from Jiangsu Hengrui Medicine, Jazz Pharma, Roche, and RemeGen.

Patients with heavily pretreated microsatellite stable metastatic colorectal cancer (CRC) had survival benefits after using ...

The trillions of microbial cells in our gastrointestinal tract have their own genomes and metabolic products, many of which ...

Data from the ongoing Phase 2 of EO4010 demonstrate tumor target specific immune responses and objective tumor responses, including in liver ...

Overall survival at 5 years for individuals who received a liver transplant for certain cancers is deemed adequate.